EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Arcadia Biosciences's Enterprise Value is $-2.95 Mil.
Arcadia Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.25 Mil. Therefore, Arcadia Biosciences's EV-to-FCF for today is 0.69.
The historical rank and industry rank for Arcadia Biosciences's EV-to-FCF or its related term are showing as below:
RKDA'
s EV-to-FCF Range Over the Past 10 Years
Min: -5.4 Med: -0.07 Max: 1.46
Current: 0.69
During the past 13 years, the highest EV-to-FCF of Arcadia Biosciences was 1.46. The lowest was -5.40. And the median was -0.07.
RKDA's EV-to-FCF is ranked better than 97.48% of 1190
companies
in the Consumer Packaged Goods industry
Industry Median: 15.41
vs RKDA: 0.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Arcadia Biosciences's PE Ratio (TTM) for today is calculated as:
Arcadia Biosciences's share price for today is $0.719.
Arcadia Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.730.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Arcadia Biosciences EV-to-FCF Related Terms
Arcadia Biosciences EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Arcadia Biosciences's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Arcadia Biosciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcadia Biosciences EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Arcadia Biosciences's EV-to-FCF falls into.
Arcadia Biosciences's current Enterprise Value is $-2.95 Mil.
Arcadia Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcadia Biosciences (RKDA) has a EV-to-FCF of 0.69 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Arcadia Biosciences and its competitors. According to the industry distribution chart, Arcadia Biosciences ranks #30 out of 1190 companies in the Consumer Packaged Goods industry, placing it in the top 2.5%.
Is Arcadia Biosciences' EV-to-FCF too high?
Arcadia Biosciences' current EV-to-FCF is 0.69. The Consumer Packaged Goods industry median EV-to-FCF is 15.41. Arcadia Biosciences' value of 0.69 is 95.5% below this industry median. Based on the distribution chart, Arcadia Biosciences ranks #30 out of 1190 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' EV-to-FCF compare to CIMG and ARRT?
According to the Consumer Packaged Goods industry distribution chart, Arcadia Biosciences ranks #30 out of 1190 companies for EV-to-FCF. This places Arcadia Biosciences in the top 3% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 15.41. Arcadia Biosciences' value of 0.69 is 95.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.41, based on 1,190 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcadia Biosciences's current EV-to-FCF of 0.69 is 95.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Arcadia Biosciences and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcadia Biosciences's current EV-to-FCF is 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.77, compared to a current price of $0.72 — trading 74% below its estimated fair value. The current EV-to-FCF is 0.69 and 95.5% below the Consumer Packaged Goods industry median of 15.41. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current EV-to-FCF is 0.69 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcadia Biosciences (RKDA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued.
The current stock price of $0.72 is trading 74% below its estimated GF Value™ of $2.77.
GuruFocus considers Arcadia Biosciences to be Possible Value Trap.
Key valuation signals for RKDA:
EV-to-FCF: 0.69
GF Value™: $2.77 vs. price of $0.72 (74% below fair value)
Industry Position: 95.5% below the Consumer Packaged Goods median (#30 of 1190)
No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score
Get the complete analysis for RKDA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RKDA has been successfully added to your 
